Loading insider details...
Beta
Latest Form 4 (Dec 10, 2025): Conversion of 1,250,000 OVID shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Dec 10, 2025 | Ovid Therapeutics Inc. (OVID) | Conversion | 1,250,000 | n/a |
| Sep 19, 2025 | HilleVax, Inc. (HLVX) | Tender of Shares | 6,724,000 | $13.11M |
| Jan 25, 2024 | Phathom Pharmaceuticals, Inc. (PHAT) | Sale | 3,703,703 | $30.00M |
| May 26, 2023 | Calithera Biosciences, Inc. (CALA) | Other (see footnotes) | 1,000,000 | n/a |
| Dec 1, 2022 | HilleVax, Inc. (HLVX) | In-the-Money Exercise | 5,883,500 | n/a |
| Jul 6, 2022 | Ovid Therapeutics Inc. (OVID) | Other (see footnotes) | 5,750,000 | n/a |
| Jul 6, 2022 | Calithera Biosciences, Inc. (CALA) | Other (see footnotes) | 1,000,000 | n/a |
| Mar 17, 2022 | Phathom Pharmaceuticals, Inc. (PHAT) | In-the-Money Exercise | 7,359,304 | n/a |
| Dec 9, 2021 | Day One Biopharmaceuticals, Inc. (DAWN) | Sale | 128,745 | $2.37M |
| Dec 7, 2021 | Day One Biopharmaceuticals, Inc. (DAWN) | Sale | 12,517 | $231.2K |